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Abstract 
This article reviews the varied sources of oligosaccharides available in nature as silent health promoting, integral 
ingredients of plants as well as animal products like honey and milk. The article focuses on exotic and unfamiliar 
oligosaccharides like Galactooligosaccharides, Lactulose derived Galactooligosaccharides, Xylooligosaccharides, 
Arabinooligosaccharides and algae derived Marine oligosaccharides along with the most acknowledged prebiotic 
fructooligosaccharides. The oligosaccharides are named as on the grounds of the monomeric units forming oligom-
ers with functional properties. The chemical structures, natural sources, microbial enzyme mediated synthesis and 
physiological effects are discussed. An elaborate account of the different types of oligosaccharides with special refer-
ence to fructooligosaccharides are presented. Finally, the profound health benefits of oligosaccharides are rigourously 
discussed limelighting its positive physiological sequel.
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Introduction
Food industry is presently witnessing an upcoming 
market for edible products having health benefits apart 
from nutrition, now well recognized as functional foods. 
The market of functional foods is facing an increas-
ing demand also because of consumer awareness about 
health. According to the Global Industry Analyst (GIA) 
report on the demand of prebiotics, based on studies 
in market trends in countries like US, Canada, Japan, 
Europe (France, Germany, Italy, UK, Spain, Russia and 
rest of Europe), Asia–Pacific (China, India and Rest of 
Asia–Pacific) and rest of World, the industry is likely to 
flourish to a tune of US $4.8 billion by 2018 from US $1.0 
billion in 2011 (Spinner 2013).
Japan is one of the leading countries giving importance 
to functional food market focusing on “Food of Specified 
Health Use” (FOSHU). Many European countries like 
Germany, France, United Kingdom and Netherlands have 
also showed an extended demand for functional foods 
(Katapodis et al. 2004; Menrad 2003).
Since past three decades there has been constant evalu-
ation of market trend of western countries witnessing 
increased demand of functional foods. Even in develop-
ing country like India, where the dairy industry is one of 
the main industries supporting economy, there has been 
a significant rise in demand of value added dairy prod-
ucts encompassing health benefits to the consumers 
(Gour 2013).
Prebiotics and probiotics have raised as best option for 
quench of the increasing need of functional food. Rober-
froid (2000) studied probiotics and prebiotics food and 
reviewed their properties to be rightly labeled as func-
tional foods. He explained that prebiotics are non-digest-
ible food ingredients that benefit the host by selectively 
stimulating the growth or activity of one or limited num-
ber of bacteria in colon.
Food ingredients which naturally offer resistance to 
digestion, when reach the intestine exhibit a favoring 
effect on normal flora of the colon are called as prebi-
otics. Prebiotics encompass several health benefits like 
the calorie-free nature, act as artificial sweeteners, have 
non-carcinogenic nature and stimulate the growth of 
Bifidobacterium and probiotic Lactobacilli in the colon 
(Saminathan et  al. 2011). They possess preventive effect 
against colon cancer (Moore et  al. 2003). They have 
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ability to decrease cholesterol levels in the serum (Fer-
nandez et al. 2003). Phospholipids and triglyceride levels 
are also found to be regulated in the serum by prebiotic 
food (Katapodis et  al. 2004). Fructooligosaccharides 
(FOS) are gaining wide acceptance as prebiotics (Belorkar 
et al. 2013). This mini review presents an overview of the 
types of oligosaccharides existing in nature, their sources 
and major thrust applications.
Oligosaccharides: types, sources and applications
Extensive research has been done on various types of oli-
gosaccharides. They differ in their nature of monomeric 
sugars and are named so. They have varied sources of ori-
gin and differ in their benefits imparted to the consumer. 
The most popular oligosaccharides are FOS, Galac-
tooligosaccharides (GOS), Lactulose derived galactoo-
ligosaccharides (LDGOS), Xylooligosaccharides (XOS), 
Arabinooligosaccharides (AOS), algae derived marine 
oligosaccharides (ADMO). Other oligosaccharides occur-
ring in nature are Pectin-derived acidic oligosaccharides 
(pAOS), Maltooligosaccharides (MOS), Cyclodextrins 
(CD) and human milk oligosaccharides (HMO) with 
specific acknowledged benefits. The oligosaccharides 
have great industrial applications (Crittenden and Playne 
1996; Prapulla et  al. 2000). The chemical structure of 
some important oligosaccharides are given in Fig. 1.
Structure of fructooligosaccharides
FOS consist of a fructose units polymerized to different 
extent. Oligomers with two fructose units are called as 
1-kestose. Oligomers with three fructose units are called 
as 1-nystose. Oligomers with four fructose units are 
called as 1-fructofuranosyl-nystose. The sugars are linked 
by β-2, 1 position of sucrose (Sangeetha et al. 2005).
Occurrence of FOS
Varieties of sources cater fructooligosaccharides in vary-
ing concentrations as its natural component like wheat, 
honey, onion, garlic and banana (Roberfroid and Slavin 
2000). Barley and tomato contains 0.15  % of fructoo-
ligosaccharides. Banana and brown sugar has 0.30  % 
fructooligosaccharides. Honey has 0.75 % of fructooligo-
saccharides (Flamm et al. 2001).
Bornet et  al. (2002) recorded the occurrence of short 
chain FOS in many edible plants. Fructooligosaccha-
rides expresses degree of polymerization from 1 to 5 
Fig. 1 Overview of structure of some common oligosaccharides
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units of fructose. Short chain oligosaccharides are simi-
lar to dietary fibers in resisting digestion in intestine and 
getting converted to acetate, propionate, butyrate and 
gas in colon. Fructooligosaccharides also add up to the 
fecal matter and gives improved bowel movement. In 
the digestive tract they promote Bifidobacterium and on 
other hand have an inhibitory effect on Clostridium per-
fringes in colon.
FOS are found abundantly in nature as a component 
of cereals, fruits and vegetables next to starch specified 
in Fig. 2 (Sangeetha et al. 2005). These exhibit resistance 
to basic enzymes involved in digestion like alpha amyl-
ase, saccharase and maltase when investigated in humans 
(Losada and Olleros 2002).
Johnson et  al. (2013) reported that lentils are rich in 
prebiotics. There is a significant variation in prebiotic 
carbohydrate composition of different types of lentils. 
They analyzed Raffinose-family oligosaccharides, sugar 
alcohols, fructooligo-saccharide and resistant starch 
carbohydrates. They recorded the occurrence of Raffi-
nose-family oligosaccharides, sugar alcohols, fructooli-
gosaccharides and resistant starch as 4071, 1423, 62 and 
7500 mg per 100 g dry matter, respectively.
Fructosyltransferase enzyme
Some plants and microorganisms express fructosyl-
transferase enzyme naturally. The activity of this enzyme 
empowers these organisms to synthesize fructooligosac-
charides (Sanchez et al. 2008). Fructosyltransferase enzyme 
from different sources exhibit different mechanisms of 
action and produce different mixtures of oligosaccharides.
Beneficial health effects of FOS on consumers
FOS are receiving attention and importance not merely 
because of their application as alternative sweeteners 
but rather for the accompanied desirable characteristics. 
The earlier known health benefits of FOS were inhibi-
tory effect on pathogens and stimulatory effect on Bifi-
dobacterium. The FOS was analyzed further to highlight 
its detailed interaction with Bifidobacterium (probiotics) 
which paved a pathway for the concept of synbiotics (Per-
rin et al. 2001; Vander et al. 2004). The health benefits of 
FOS have been reviewed by many workers (Antosova and 
Polakovic 2001; Hernandez et  al. 2009; Patel and Goyal 
2011; Ganaje et al. 2014).
Some of the evident health benefits observed by con-
sumption of fructooligosaccharides include the following:
Fig. 2 Distribution of FOS in various natural products
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Promotes growth of the gut micro flora
Studies on Bifidobacterium species revealed that fruc-
tooligosaccharides preferred those carbohydrates which 
allow maximum growth and metabolic activities of this 
beneficial flora in human intestine (Palframan et  al. 
2003). The diet and its composition have an impact on 
gut and its microflora. It has been observed that any 
kind of change in the diet affects the metabolism of the 
inhabitants. The dietary fibres like oligosaccharides exert 
a combined effect on both the pH environment of the gut 
and the metabolism of bacterial community (Chen et al. 
2000; Flint et al. 2007).
Prebiotics have multidimensional effect on host‑bacteria 
interaction
It is now well established fact that host bacteria inter-
actions are highly specific with varied dimensions. The 
digestion resistant carbohydrates in the gut are fer-
mented in the colon which causes increase in the serum 
lactate levels. The study was conducted on horses by 
injecting fructooligosaccharides directly in caecum and 
acidotic state was maintained. Its effect on caecum bacte-
ria and metabolites were analyzed. Streptococcal species 
(EHSS) showed positive relation with caecum lactate and 
negative response with serum lactate; however, serum 
lactate has a positive influence on Enterobacteriaceae 
(Rudi 2010).
Genetic features direct the probiotic effect of bacteria
Excellent studies on genomics of lactic acid bacteria in 
relation to their role in functional foods have been done 
by Klaenhammer et al. (2005). Their findings discovered 
that many genetic features exert control over the bacte-
rial metabolic and probiotic process.
Development of resistance to ill effects of bile salts
Fructooligosaccharides and their monomeric derivatives 
offer resistance against the ill effects of bile salts on Bifi-
dus group of intestinal inhabitants. Perrin et  al. (2001) 
studied the inhibitory effect of bile salts on three strains 
of Bifidobacterium in medium containing any carbohy-
drate source. In presence of fructooligosaccharides in 
the medium the Bifidobacterium improved their resist-
ance and demonstrated better growth in presence of 
bile salts. Macfarlane et  al. (2008) studied the effect of 
inulo, galacto and fructooligosaccharides was extremely 
favorable for Bifidobacterium and also Lactobacilli but to 
a lesser extent. Their health benefits encompass features 
like putative anti-cancer properties, mineral absorption, 
lipid metabolism, anti-inflammatory and other immune 
effects such as atopic disease.
Promotes preferential growth of Bifidus
A statistical model was used by Shuhaimi et al. (2009) for 
the study of growth of Bifidobacterium pseudocatenu-
latum G4 under the influence of prebiotic. The physi-
ological effect of inulin and fructooligosaccharides were 
investigated with sorbitol, arabinan and inoculum rate. 
Fractional factorial design was used to determine their 
effect on growth of selected bacterium in skimmed milk. 
They optimized their growth conditions and concluded 
that in 1  L fermentor, the yield increase and Central 
Composite Design was very effective in optimization of 
medium for growth of Bifidus. In a similar study, Ketabi 
and Dieleman (2011) investigated the effect of isomalto-
oligosaccharides on intestinal microflora of rats and 
inferred that it specifically stimulated the growth of 
Lactobacilli.
Removal of cholesterol
Cholesterol was found to be evidently removed by Lacto-
bacillus acidophilus ATCC 4962 in the presence of prebi-
otics in a study conducted by Liong and Shah (2005). The 
effect of six prebiotics including fructooligosaccharides 
was used to investigate the best combination for effec-
tive removal of cholesterol. The first-order model, the 
second-order polynomial regression model and quadratic 
models were used in their study.
Artificial sweetness
Apart from all the above stated prime health benefits 
fructooligosaccharides also has artificial sweetness and 
low caloric value. Artificial sweeteners are constantly in 
demand due to need of diabetics and health conscious 
consumers. Initially the demand was satisfied by aspar-
tame agent or natural sweeteners like palatinose. Due to 
their popular use all types of oligosaccharides remained 
poorly exploited despite their functional properties 
(Mussatto et al. 2009).
Role in osteoporosis
The most recent trial of fructooligosaccharides supple-
mented with calcium in post menopausal women have 
registered beneficial effects in bone mineral density which 
is highly significant in osteoporosis (Slevin et al. 2014).
Galactooligosaccharides (GOS) and Lactulose 
derived galactooligosaccharides (LDGOS)
Mammalian milk is the natural source of GOS. Indus-
trially trans galactosylation of lactose present in whey 
catalysed by β-galactosidases is gaining momentum as an 
promising alternative for synthesis of GOS (Affertsholt-
Allen 2009).
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β-Galactosidase is a hydrolase that attacks the o-gluco-
syl group of lactose. The general mechanism of enzymatic 
lactose hydrolysis has a transgalactosylic nature, involv-
ing a multitude of sequential reactions with disaccharides 
(other than lactose) and higher saccharides, collectively 
named galacto-oligosaccharides (GOS), as intermediate 
products (Wallenfels and Malhotra 1960; Goulas et  al. 
2007). Non digestible oligosaccharides have wider appli-
cations (Sako et al. 1999).
The GOS are complex mixtures of oligosaccharides 
ranging from two to eight moieties, and different glyco-
sidic linkages: β-(1,1), β-(1,2), β-(1,3), β-(1,4) and β-(1,6) 
(Playne and Crittenden 2009). The hydrolytic enzymes 
preferentially expressed by Bifidobacterium species spe-
cifically target β-glycosidic linkages of GOS in the intes-
tine (Macfarlane et al. 2008).
Microbes are exuberant sources of the enzymes pro-
ducing Lactulose and GOS (Nguyen et al. 2009; Splechtna 
et al. 2006, 2007; Maischberger et al. 2008; Placier et al. 
2009). The operation conditions are to be properly moni-
tored for optimal ratio of lactulose and GOS for potential 
synthesis of prebiotics (Guerrero et al. 2013; 2015).
The main physiological effects of GOS are related with 
their composition and activities of the intestinal microbiota 
(Algieri et  al. 2014). The human intestinal tract harbors a 
complex community of bacteria, eukaryotic microorganisms, 
archaea, viruses, and bacteriophages, collectively referred to 
as the intestinal microbiota. Bacteria account for the major-
ity of these microorganisms: their total number in the human 
gut is estimated at 1014 cells mainly present in the colon 
(Backhed et al. 2005; Lupp and Finlay 2005). The wide appli-
cations of GOS and LDGOS are represented in Fig. 3.
Xylooligosaccharides (XOS)
Xylooligosaccharides or feruloyl oligosaccharides are 
known to be produced by Aspergillus, Trichoderma, Peni-
cillium, Bacillus and Streptomyces. It is found in plant 
sources like Bengalgram husk, wheat bran and straw, 
spentwood, barley hulls, brewery spent grains, almond 
shells, bamboo and corn cob. XOS mainly exerts prebi-
otic effect in consumers.
These unusual oligosaccharides are composed by 
chains of xylose moieties linked by β-(1,4) bonds, 
with a polymerization degree ranging from two to ten 
monosaccharides.
It is also known to act as a plant growth regulator. It 
has multidimensional applications as antioxidant and 
gelling agent in food products, beneficial for diabetes, in 
treatment of arteriosclerosis, reduces total cholesterol 
and LDL in patients with type 2 diabetes mellitus and in 
colon cancer (Chung et al. 2007; Sheu et al. 2008; Lecerf 
et al. 2012; Moure et al. 2006; Katapodis and Chistako-
poulos 2008; Madhukumar and Muralikrishna 2010). 
Figure 4 is a diagrammatic representation of applications 
of XOS.
Arabinooligosaccharides (AOS)
Arabinooligosaccharides are yet another class of oligo-
saccharides which hold the potential of being labelled 
as prebiotics. The exuberant source of AOS is arabinan 
polysaccharide a branched pectic polysaccaharide 
exhibiting linkage of 1,3 and 1,5 α l -arabinofurano-
syl residues (Vogel 1991). Arabinose occurs naturally 
in arabinans, arabinogalactans or arabino xylans pre-
sent in plants cell wall components. The nature of 
linkages differ depending upon the sources. The brush 
border epithelial cells of the intestine are inefficient to 
degrade the polysaccharides present in plant cell wall. 
This resistance of cell wall polysaccharides towards 
intestinal hydrolysis confer them the potential to be 
used as prebiotics (Yoo et al. 2012; Rastall and Hotch-
kiss 2003). The efficacy of the prebiotic effect of AOS 
is structure dependent (Casci et al. 2006; Gullón et al. 
2011).
Initially the extraction was practiced by hot alkali treat-
ment (Cibe 2003) of sugar beet dried pulp (5.5 million 
tons) a major coproduct of beet sugar industries residue 
in European countries.
AOS can also obtained by enzymatic hydrolysis of 
Arabinose containing polymers. Beldman et  al. (1997) 
classified the Arabinan degrading enzymes in six classes-
(i) α-l-Arabinofuranosidase (EC 3.2.1.55), which is not 
active with polymers (Komae et  al. 1982; Weinstein 
and Alber sheim 1979).Fig. 3 Functions of GOS and LDGOS
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(ii) α-l-Arabinofuranosidase, which is active with 
polymers (Kaji and Tagawa, 1970; Rombouts et  al. 
1988).
(iii) α-l-Arabinofuranohydrolase, which is specific 
for arabinoxylans (Kormelink et  al. 1991; Van Laere 
et al. 1997).
(iv) exo-α-l-Arabinanase, which is not active 
with  p-nitrophenyl-α-l-arabinofuranoside (Kaji and 
Shimokawa1984; McKie et al. 1997).
(v) β-l-Arabinopyranosidase (Dey 1983; Kaji and Saheki 
1975).
(vi) endo-1, 5-α-l-Arabinanase (EC  3.2.1.99) (Vora-
gen et al. 1987).
The various degree of polymerization (dp) are obtained 
when subjected to ultrafiltration can produce Oligosaccha-
rides of uniform molecular weight (Matsubara et al. 1996; 
Jian et al. 2013). AOS derived from sugar beet pectin (Al-
Tamimi et al. 2006) and lemon peel (Hotchkiss et al. 2010) 
support the intestinal bifidus flora nearly equal to FOS and 
Inulooligosaccharides (Gómez et al. 2015; Palframan et al. 
2002; Rycroft et al. 2001; Sanz et al. 2005). The extent of 
response is directly proportional to the dp of the oligosac-
charide (Sulek et al. 2014; Westphal et al. 2010).
Apart from the normal benefits, AOS is reported to 
reduce the inflammatory conditions in Ulcerative coli-
tis patients. Invitro experiments have proved about spe-
cific stimulation of Bifidobacterium and Lactobacillus 
accompanied by production of SCFA acetate which is well 
known stimulator of anti inflammatory response. AOS 
can prove to be a boon for patients suffering from Ulcera-
tive colitis after in vivo confirmation (Vigsnæs et al. 2011).
Algal-oligosaccharides lysate (AOL) and neoagarooli-
gosaccharides (NAOS) occur in the algal polysaccha-
ride extracts (APEs) of Gracilaria and Monostromaand 
inenzymatic hydrolysis of agarose. They have a prebiotic 
effect and also act as an antioxidant (Wu et al. 2005; Hu 
et al. 2006).
Fig. 4 Functions of XOS
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Algae‑derived marine oligosaccharides
Recently, algae are reported to contain bipolysaccha-
rides (Stengel et  al. 2011; Barra et  al. 2014). The bioac-
tive components mainly include glucose, starch and other 
polysaccharides (Hamed et  al. 2015). Besides these, oli-
gosaccharides are another group of carbohydrates with 
small dp containing 3–10 sugar units, ranging from 
disaccharides and/or carbohydrates with up to 20 resi-
dues with defined functions (Patel and Goyal 2010).
The chemical structure and conformation decides the 
classification of algae-derived marine oligosaccharides 
namely chitosan-, laminarin-, alginate-, fucoidan-, carra-
geenan- and ulvan-oligosaccharides.
The note worthy bioactive compounds in Marine mac-
roalgae or seaweeds is namely polysaccharides, tannins, 
and diterpenes. (O’sullivan et al. 2010). These ingredients 
may lead a pivitol role in nutraceuticals (Milinki et  al. 
2011). The functions of ADMO are given in Fig. 5.
Other oligosaccharides
Mannanoligosaccharides (MOS) are mainly isolated 
from cell wall fragments of yeast. It was found to alter 
the gut microflora in fishes. It has been used as an alter-
native to antibiotics and added to improve the nutritive 
value of broiler diets (Dimitroglou et  al. 2010; Eseceli 
et  al. 2010). Chitosanoligosaccharides (COS) has been 
recorded to be produced by depolymerisation of chi-
tosan. They are mainly used as an antioxidative agent, 
anti-tumor agent and anti-microbial agent. Chitosan 
oligosaccharides have been recorded to protect normal 
cells from apoptosis (Liu et  al. 2010). Human milko-
ligosaccharide (HMO) naturally occurs in human breast 
milk. It signifies the preferential growth of Bifidobacte-
rium and Lactobacilli in the colon of mother fed babies 
(Quigley 2010). Gentiooligosaccharides (GeOS) is pro-
duced by digestion of starch and mainly used as a prebi-
otic (Cote 2009; Fujimoto et al. 2009).
Fig. 5 Functions of AOS
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Pectin-derived acidic oligosaccharides (pAOS) occur 
in higher plant products like fruits and vegetables. It 
mainly finds its applications in infant formulae to sub-
side diarrhoea, increase absorption of minerals and 
calcium ions and also has antioxidant effects (Liu et al. 
2010). pAOS also successfully helped in the lung infec-
tions by modulating the intestinal microbiota and the 
inflammatory and immune responses (Bernard et  al. 
2015). Cyclodextrins (CDs) are produced by transfor-
mation of starch by Bacillus macerans. It is used as a 
stabilizer for volatile compounds in food preparations 
and chemicals. It acts as an antioxidant. It is used as 
taste enhancers in bitter medicines and food items 
(Astray et al. 2009; Courtois 2009).
Although all oligosaccharides are exhibiting prebi-
otic properties but fructo-oligosaccharides has gained 
much attention as artificial sweeteners because they 
provide sweet taste to the consumer and do not increase 
the blood glucose level. Therefore, they find important 
place in the food of diabetics. Thus, fructooligosaccha-
rides act as artificial sweeteners with functional prop-
erties apart from sweetness similar to that of natural 
sweeteners.
Oligosaccharides from various sources have been con-
sidered as boon due to health benefits they encompass 
along with property of being used as an artificial sweetner. 
Due to the diversified health benefits conferred by them, 
they have earned a prominent recognition as Nutraceu-
ticals presently limelighted in the health market. The 
microbial production of enzymes catering the catalysis 
of oligosaccharides are now targeted by the biotechnolo-
gists for their optimum synthesis. Microorganisms, espe-
cially molds have been the most prominent microbe for 
enzymatic synthesis of the prebiotic oligosaccharides. 
Since 1980s teeming research work was focused towards 
isolation of potent microbes for oligosaccharide synthe-
sis. The oligosaccharide production has been successfully 
attempted employing diverse approach viz. SmF, SSF, 
immobilization of the intact microbial cells or derived 
enzymes. The successful attempts have been made to 
improve the strain through mutations.
These laboratory processes have although recorded 
successful production of oligosaccharides but scaling 
up introduces exuberant increase in the cost of produc-
tion of oligosaccharides. The bio process improvement 
should be inculcated using cheaper agro-industrial 
wastes as substrates for oligosaccharide production. To 
decrease the cost of production following issues have to 
be addressed: (i) a potent and stable microbial enzyme 
source is to be fetched (ii) scrutinizing agro-industrial 
wastes befitting the oligosaccharide production (iii) 
cheaper alternatives for purification strategies of synthe-
sized oligosaccharides.
Future prospects
As stated in the introduction of the review the demand 
of health promoting food is expected to rise up to US 
$4.8 billion by 2018. The hike in the demand is indicative 
of the future directions towards which the food indus-
try is fastly marching. The so called health promoting 
food or pro and prebiotics under the unanimous label 
of “Nutraceuticals” will be a focus of attraction for every 
such layman growing conscious about health in near 
future. The present scenario of the health market trend 
is facing certain health issues pertaining to intake of 
the prebiotics viz. aggravation of intolerance to lactose, 
increments in allergic responsiveness of sensitive indi-
viduals as reported in several human based case studies.
Looking forward with this setback associated with 
probiotics, prebiotic are coming up as more promis-
ing option. Above all the prebiotic effect of oligosaccha-
rides are now extended to their antidiarrheal, antiobesity 
and presently towards suppression of type 2 diabetes. 
The future would really depend on the synergistic effect 
developed by combinational use of prebiotics and pro-
biotics. The incremental benefits of synbiotics would be 
auxiliary to the nature’s boon.
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